Co-Diagnostics hosts investor presentation on ReadyGo collaboration, Co-Dx PCR platform, India ops

Co-Diagnostics, Inc.

Presentation dated September 16, 2026 covers collaboration with ReadyGo Diagnostics Ltd.
Topics include Co-Dx PCR platform development, manufacturing initiatives, and India operations.
No financial metrics or guidance disclosed in the 8-K body; details appear in presentation materials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.